Abstract:Gene expression involves transcription and translation. Despite large datasets and increasingly powerful methods devoted to calculating genetic variants’ effects on transcription, discrepancy between messenger RNA and protein levels hinders the systematic interpretation of the regulatory effects of disease-associated variants. Accurate models of the sequence determinants of translation are needed to close this gap and to interpret disease-associated variants that act on translation. Here we present Translatomer, a multimodal transformer framework that predicts cell-type-specific translation from messenger RNA expression and gene sequence. We train the Translatomer on 33 tissues and cell lines, and show that the inclusion of sequence improves the prediction of ribosome profiling signal, indicating that the Translatomer captures sequence-dependent translational regulatory information. The Translatomer achieves accuracies of 0.72 to 0.80 for the de novo prediction of cell-type-specific ribosome profiling. We develop an in silico mutagenesis tool to estimate mutational effects on translation and demonstrate that variants associated with translation regulation are evolutionarily constrained, both in the human population and across species. In particular, we identify cell-type-specific translational regulatory mechanisms independent of the expression quantitative trait loci for 3,041 non-coding and synonymous variants associated with complex diseases, including Alzheimer’s disease, schizophrenia and congenital heart disease. The Translatomer accurately models the genetic underpinnings of translation, bridging the gap between messenger RNA and protein levels as well as providing valuable mechanistic insights for uninterpreted disease variants. A transformer-based approach called Translatomer is presented, which models cell-type-specific translation from messenger RNA expression and gene sequence, bridging the gap between messenger RNA and protein levels as well as providing a mechanistic insight into the genetic regulation of translation.

Long noncoding RNAs are rarely translated in two human cell lines

Discovering putative peptides encoded from non-coding RNAs in ribosome profiling data of Arabidopsis thaliana.

Methods for distinguishing between protein-coding and long noncoding RNAs and the elusive biological purpose of translation of long noncoding RNAs

Long Noncoding RNA: Genomics and Relevance to Physiology.

In-depth characterization and identification of translatable lncRNAs

Long non-coding RNAs as a source of new peptides

The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression

Revision of Functionally Relevant and Widely Expressed Long Non-Coding RNAs

A Hidden Human Proteome Encoded by 'Non-Coding' Genes

Translation and natural selection of micropeptides from long non-canonical RNAs

Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome

Cytoplasmic long noncoding RNAs are differentially regulated and translated during human neuronal differentiation

Comparative Analysis Of Human Protein-Coding And Noncoding Rnas Between Brain And 10 Mixed Cell Lines By Rna-Seq

Translation of noncoding RNAs and cancer

Global and Cell-Type Specific Properties of Lincrnas with Ribosome Occupancy.

Micropeptides translated from putative long non-coding RNAs

An atlas of human long non-coding RNAs with accurate 5′ ends

Predictive models of subcellular localization of long RNAs

Human Long Noncoding RNAs Are Substantially Less Folded Than Messenger RNAs

Deep Learning Prediction of Ribosome Profiling with Translatomer Reveals Translational Regulation and Interprets Disease Variants

Clinical prospects and research strategies of long non-coding RNA encoding micropeptides.